4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-120080
Chief Dev. & Ops. Officer bought 300 shares at an average $7.15 ($2,145)
From the SEC's structured data for this filing
Trades in this filing
Shemesh Shay · Chief Dev. & Ops. Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-16 | Purchase : show line 1 in the form | +150 | $7.10 | $1,065 | 1,245,215 | D |
| 2022-11-17 | Purchase : show line 2 in the form | +150 | $7.20 | $1,080 | 1,245,365 | D |
| Open-market purchases · 300 sh · avg $7.15 · $2,145 | ||||||
Loading xslF345X03/tm2230911-1_4seq1.xml…